This grand round has already taken place.
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. It affects certain cells in the immune system called B cells and T cells. ALL usually affects B cells in children.
The new classification of B-ALL includes ETV6::RUNX1 like, TCF3::HLF fusion, B-ALL with other defined genetic alterations. Here in we will learn the main cytogenetic abnormalities as well as their prognosis in pediatric B-ALL.
Dates and Times
Start: 9/27/2023 12:00 PM
End: 9/27/2023 1:00 PM
1) To understand the main chromosomal abnormalities in B-ALL
2) To understand the difference between standard risk and high risk in pediatric B-ALL
3) To monitor a patient with B-ALL.
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Please contact the Grand Round coordinator listed below: